CAS: 13171-64-7; (2S,3S)-Dimethyl 2,3-Dihydroxysuccinate

该化合物是一种有机化合物,其特征为来自酸盐的狄氏功能组,具有两种氢氧基和两个酯组,有助于其在水和酒精等极溶剂中的溶解性.该化合物一般是无色的,可粉色黄色,有甜的果味.其立体化学由(2S,3S)配置界定,表明其手工业中心的具体空间安排,可影响其生物系统中的再活动与互动.二甲基酸盐用于各种应用,包括作为有机合成的脊髓建筑块和制药生产中的潜在中间体.此外,该化合物可作为调味剂或某些化妆品的配制.安全数据表明,应谨慎处理该物质,因为接触皮肤或眼睛可能会引起刺激.

结构式图片

相似化合物

608-68-4 133-37-9 147-71-7

合成工艺路线路线简述

  • 合成目标产物 (-)-Dimethyl D-Tartrate 主要起始原料 Dimethyl Fumarate
  • (文献来源)合成步骤主要原料 Dimethyl Fumarate

海关参考信息

专利信息


专利号:US-8404088-B2
优先权日:2006-05-22
标 题:Asymmetric synthesis of rocaglamides via enantioselective photocycloaddition mediated by chiral bronsted acids
发明人:PORCO JR JOHN A; GERARD BAUDOUIN
权利人:PORCO JR JOHN A; GERARD BAUDOUIN; UNIV BOSTON
摘要:The present invention provides a new strategies for the synthesis of compounds of the rocaglamide family and related natural products. The synthetic approach generally involves photochemical generation of an oxidopyrylium species from a 3-hydroxychromone derivative followed by an enantioselective 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile in the presence of a TADDOL derivative. This approach can be used for the formation of adducts containing an aglain core structure. Methods of the conversion of aglain core structures to aglain, rocaglamide and forbaglin ring systems are also provided. The present invention also relates to the use of rocaglamide/aglain/forbaglin derivatives for the manufacture of medicaments for use in the treatment of cancer or cancerous conditions, disorders associated with cellular hyperproliferation, or NF-κB-dependent conditions.

专利号:US-7393954-B2
优先权日:2002-12-12
标题:Process for the production of pentostatin aglycone and pentostatin
发明人:NADJI SOURENA; SMOOT JAMES; SAMPATH UMASHANKER
权利人:RELIABLE BIOPHARMACEUTICAL COR
摘要:A novel, scaleable and improved process for preparing pentostatin and its analogs is disclosed. The method comprises the diastereospecific synthesis of the nucleobase from commercially available L-Dialkyl tartarates.

专利号:US-7812193-B2
优先权日:2003-09-19
标题:Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
发明人:REBIERE FRANCOIS; DURET GERARD; PRAT LAURENCE
权利人:CEPHALON FRANCE
摘要:The invention relates to a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form, comprising the steps of:n a) contacting a pro-chiral sulphide of formula (II) with a metal chiral complex, a base and an oxidizing agent in an organic solvent; and optionally b) isolating the obtained sulphoxide of formula (I); nn nwherein n, Y, R 1 , R 1a , R 2 and R 2a are as defined herein.

专利号:US-2005222257-A1
优先权日:2003-09-19
标题:Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation

专利号:US-7317126-B2
优先权日:2003-09-19
标 题:Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation

专利号:CA-2538697-C
优先权日:2003-09-19
标 题 :Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
成都丽凯手性技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lkchiralchina.com
电话: 028-85233564👤
📞成都丽凯手性技术有限公司 ⚠️参考联系方式

销售电话:028-85233564
邮箱:sales@lkchiralchina.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/bf00563684
摘要:Berlin YA, Kolosov MN, Piotrovich LA. Olivomycin and related antibiotics XXVI. The absolute configurations of olivin and of chromomycinone. Chemistry of Natural Compounds. 1972 Jul;8(4):515–21. doi: 10.1007/bf00563684.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知